# Bioscan Research

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bioscan-research

- Industry: Medical Devices & Equipment
- Headquarters: Ahmedabad, India
- Website: www.bioscanresearch.com
- Total disclosed funding: $1M
- Latest round: Seed (Jul 22, 2026)
- Investors on record: 1

## About

Founded in 2013 and headquartered in Ahmedabad, India, Bioscan Research focuses on developing diagnostic tools for healthcare providers. The company raised USD 1.000 million in Seed funding on July 22, 2026, led by Unicorn India Ventures, marking a strategic effort to bolster its market presence. Bioscan Research is led by co-founders Anupam Lavania, Co-founder and Chief Executive Officer, and Shilpa Malik, Co-founder and Chief Technology Officer.
Bioscan Research develops a portable diagnostic device designed for the non-invasive detection and assessment of traumatic intracranial hemorrhage. This device utilizes a blend of light, electronics, mechanics, and machine learning, enabling immediate assessments at the point of care, especially for paramedics and emergency medical technicians. The technology fills critical gaps in triaging patients who may not display obvious external injuries, aiming to assist healthcare providers in regions with high incidences of traumatic brain injuries and limited access to traditional imaging solutions.
The company operates a direct-to-consumer model, selling its diagnostic device to hospitals, trauma centers, and emergency medical services. Revenue is generated through both one-time purchases and subscription agreements for ongoing support and maintenance. The pricing is structured to meet the specific needs of healthcare providers, ensuring accessibility in urgent care settings, which aligns with their objective of enhancing trauma assessment capabilities and patient outcomes.
With the USD 1.000 million raised in Seed funding, Bioscan Research aims to expand its market reach and customer base significantly. The funds will be utilized to obtain additional regulatory approvals, enhance existing products, and innovate new intellectual property. The company is focused on penetrating new geographic markets, particularly targeting regions with pressing healthcare needs, and plans to roll out new products that enhance diagnostic capabilities in the upcoming years.

## Funding rounds

- Seed, Jul 22, 2026, $1M — Unicorn India Ventures

## Investors

- Unicorn India Ventures (https://capitalatlas.ai/funds/unicorn-india-ventures) — Seed